Could a simple pill tame brain inflammation and slow Alzheimer's?
NCT ID NCT04804241
First seen Feb 02, 2026 · Last updated May 28, 2026 · Updated 17 times
Summary
This study tests an experimental drug called senicapoc in people with early Alzheimer's or mild cognitive impairment. The goal is to see if it can reduce inflammation in the brain and slow down memory loss. About 55 participants will take either the drug or a placebo for 52 weeks. This is a small, early-phase study to check if the drug works as expected in humans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis Alzheimer's Disease Center East Bay
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California, Davis Alzheimer's Disease Center
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.